Dolutegravir
Showing 51 - 75 of 330
HIV-1-infection Trial in London (Dolutegravir)
Not yet recruiting
- HIV-1-infection
- Dolutegravir
-
London, United KingdomChelsea & Westminster Hospital NHS Foundation Trust
Jun 23, 2021
HIV-1-infection Trial in London (Doravirine, Dolutegravir, Triple cART regimen)
Not yet recruiting
- HIV-1-infection
- Doravirine
- +2 more
-
London, United KingdomChelsea & Westminster Hospital NHS Foundation Trust
Jun 23, 2021
HIV-1-infection, Hepatic Impairment Trial (Dolutegravir)
Withdrawn
- HIV-1-infection
- Hepatic Impairment
- Dolutegravir
- (no location specified)
Jun 7, 2021
HIV-1 Infection Trial in Yaoundé (Dolutegravir 50 mg, Tenofovir disoproxil fumarate 300 mg / lamivudine 300 mg, Efavirenz 400
Completed
- HIV-1 Infection
- Dolutegravir 50 mg
- +2 more
-
Yaoundé, Cameroon
- +2 more
Aug 26, 2021
Human Immunodeficiency Virus Trial in Newark (Dolutegravir/Lamivudine)
Active, not recruiting
- Human Immunodeficiency Virus
-
Newark, New JerseySaint Michael's Medical Center
May 3, 2022
HIV Trial in Worldwide (Placebo for maraviroc (MVC), Placebo for dolutegravir (DTG), Dolutegravir (DTG))
Completed
- HIV Infections
- Placebo for maraviroc (MVC)
- +3 more
-
Los Angeles, California
- +29 more
Apr 20, 2022
HIV, Clinical Outcomes, Adverse Drug Event Trial in Salvador, São Paulo (No intervention)
Recruiting
- HIV Infections
- +3 more
- No intervention
-
Salvador, Bahia, Brazil
- +2 more
Mar 15, 2022
HIV, AIDS, Virologic Failure Trial (Maintenance on TLD treatment strategy, Individualized Care treatment strategy, Immediate
Not yet recruiting
- HIV Infections
- +2 more
- Maintenance on TLD treatment strategy
- +2 more
- (no location specified)
May 9, 2022
HIV, Hepatitis C Trial in Aurora (dolutegravir, simeprevir)
Completed
- HIV
- Hepatitis C
- dolutegravir
- simeprevir
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Feb 23, 2021
Hiv, HIV, HIV Cardiomyopathy Trial in Denmark (Dolutegravir / Lamivudine Oral Tablet)
Recruiting
- Hiv
- +5 more
- Dolutegravir / Lamivudine Oral Tablet
-
Aalborg, Denmark
- +4 more
May 26, 2021
REal-Life Cohort With DOlutegravir + LAmivudina
Recruiting
- HIV-1-infection
- Dolutegravir 50 MG
- Lamivudine 300 MG
-
Madrid, SpainAlfonso Cabello
Apr 5, 2021
Hiv Trial (DTG DT (6 x 5 mg), F/TAF TOS (3 x 60/7.5 mg))
Not yet recruiting
- Hiv
- DTG DT (6 x 5 mg)
- F/TAF TOS (3 x 60/7.5 mg)
- (no location specified)
Aug 8, 2022
Hiv, HIV, HIV Lipodystrophy Trial in Denmark (Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO],
Recruiting
- Hiv
- +6 more
- Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO]
- Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]
-
Aalborg, Denmark
- +4 more
May 21, 2021
Pediatric HIV Infection, Tuberculosis Infection Trial (rifampicin)
Not yet recruiting
- Pediatric HIV Infection
- Tuberculosis Infection
- (no location specified)
Sep 26, 2021
HIV Trial in United States (Dolutegravir + Lamivudine FDC)
Completed
- HIV Infections
- Dolutegravir + Lamivudine FDC
-
Birmingham, Alabama
- +15 more
Sep 20, 2021
Dolutegravir Plus Lamivudine Simplified Therapy
Recruiting
- HIV/AIDS
- DTG+ 3TC
-
Guangzhou, Guangdong, ChinaGuangzhou 8th People's Hospital
Jul 19, 2021
Population Pharmacokinetics of Antiretroviral in Children
Recruiting
- Minor Patient Treated by One or More Antiretroviral and for Which a Blood Test Has Been Performed
- Dolutegravir
- +6 more
-
Paris, FranceCochin Hospital
Dec 9, 2021
HIV, Pregnancy Related, Mother to Child Transmission Trial in Salvador (Dolutegravir plus lamivudine in a FDC)
Recruiting
- HIV Infections
- +2 more
- Dolutegravir plus lamivudine in a FDC
-
Salvador, BA, BrazilFundação Bahiana de Infectologia
Feb 3, 2022
HIV Trial in Baltimore (Switch to Maraviroc + Raltegravir or Dolutegravir)
Completed
- HIV
- Switch to Maraviroc + Raltegravir or Dolutegravir
-
Baltimore, MarylandUniversity of Maryland, Institute of Human Virology
Oct 5, 2021
HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)
Recruiting
- HIV-1-infection
-
Kisumu, Kenya
- +6 more
Feb 1, 2023
HIV/TB Coinfection Trial in Thailand (DTG 50 mg OD with food, DTG 50 mg BID)
Recruiting
- HIV/TB Coinfection
- DTG 50 mg OD with food
- DTG 50 mg BID
-
Chiang Rai, Chiangrai, Thailand
- +9 more
Mar 22, 2022